Puretech Health Share Discussion Threads

[volvo] 18/6/2020 15:33

Karuna holding over $100 today so $474m current value.

Imagine if both Gelesis and Akili go for billion dollars IPO's??? Double share price on announcement?

[volvo] 18/6/2020 14:57

Yes the market has missed the news...needs picking up by the brokers and should see it pass 300p.

[manual dexterity] 18/6/2020 14:09

It is indeed good progress as one has been adding to ones portfolio.

Patience is key.

[volvo] 18/6/2020 14:08

Gelesis and Akili will both been keenly bid at IPO stage.

[lendmeafiver] 18/6/2020 12:55

and as Volvo keeps saying, our stake in Gelesis is effectively for free given cash and stocks broadly backup market cap.

[af004] 18/6/2020 12:42

Great news.

[lendmeafiver] 18/6/2020 12:31

More great progress

[volvo] 17/6/2020 20:06

Ahh a response.

Yes I've stuck a few percentage of my pension fund in here. Recon on 100pc return within 24 months maybe sooner, much sooner....and 200pc return within 36 months.

Today is all about solvency and this company is silly rich with plenity of goal scorer's....see how i did that.

Basically the bottom line is this cash rich biotech company is becoming de-risked....and has so much up side potential.

These are great plays.

Karuna stopped all the doubters, it showed the model is not flawed and if you back a drug and its successful you hit the jackpot

[reddevil28] 17/6/2020 14:01

Sounds good to me. ADHD is a huge market in North America. Dipping toes in now.

[volvo] 17/6/2020 10:06

Starting to set sail now to 350p.

Karuna finished at $99 having got $101...every pip is worth $5m to Puretech, currenty at $474m.

So over $850m in cash and stock, Akili (34pc owned) and Gelesis (22pc owned and royalties) both queuing up for IPO, and 22 product candidates in varying stages from pre clinical to phase 3. So much going on.

[volvo] 17/6/2020 07:14

EndeavorRX

Analysts at Peel Hunt factor in a peak treatment rate of 300,000 patients for peak annual in-market revenue of US$390mln.

Then start to factor in Rest of World sales...Akili have crept up on the markets.

Going to get a decent valuation at IPO.

It will list in the US...along with Gelesis.

[edwardt] 16/6/2020 09:57

my understanding is the alternative therapy for kids is giving them 'speed' which is not a pleasant drug!

[volvo] 16/6/2020 09:49

worldwide tv and press will run with this story....every parent of a ADHD child will want to try it asap.

Investors will want to get on board with Akili, but its not listed yet, but we are the obvious back door in.

Can see a decent sized IPO.

[volvo] 16/6/2020 09:11

Pediatric autism, depression, and ms.

Pediatric ADHD affects 6m in the states and 10's of millions around the world.

This novel approach with a digital game will be a blockbuster and currently only on prescription.

$100 a pop and you soon have billions in sales ww.

Will take time to roll out, but everything in place for a large ramp up.

[edwardt] 16/6/2020 09:05

any idea what the other 7 candidates are for?

[volvo] 16/6/2020 08:30

.....'The FDA clearance of EndeavorRx is a tremendous milestone as it represents an entirely new class of medicine for children and their families,' PureTech founder and chief executive Daphne Zohar said'

[volvo] 16/6/2020 07:32

Finally learnt how to RNS news...theres hope.

We own 34pc of Akili, which after todays FDA approval will 100pc seek a US listing.

It must, as it now seems definite that most of the rest of its seven digital candidates will indeed get the same approvals.

They are all fresh state of the art digital offerings and have the jump on the competition who are years behind.

So a decent money making company and the only pay off for investors is a listing.

[volvo] 15/6/2020 18:06

...with Karuna now at $97 we are below cash value....and fu*k all for 23 drug candidates 13 in trials one approved....pressured sellers

[volvo] 13/6/2020 11:43

Rechecking yesterday's large trade, someone sold 1.2m shares at 260p in a standard O trade...thats quite a hefty £3.12m for a tightly held stock.

Overall less than 0.5pc.

The fact that it was bought up, every sell is a buy, every buy is a sell, market makers are generally neutral and would no way take that amount of stock on.

Could be an interesting week ahead if a seller is cleared...no resistance to the highs around £3.50

[volvo] 13/6/2020 11:12

The Vedanta cash raise was $12m for 7pc...early days for Vedanta but that would make our 54pc is worth about $90m.

Of course 22pc Gelesis plus royalties, 78pc Follica plus royalties, 46pc Sond, 73pc Entega, 78pc Alvio.....and our own very promising LYT 100 and LYT 200 and LYT 210...are currently valued @ zilch zero zip.

[volvo] 12/6/2020 17:28

yes $440m in Karuna shares and $380m cash = $820m = £655m....market cap £700m, go figure.